Company Filing History:
4 out of 36 
2 out of 2 
1 out of 1 
Years Active: 2013-2023
Title: Michael DesJardin: Innovator in Pharmaceutical Compositions
Introduction
Michael DesJardin is a notable inventor based in Aptos, California, with a significant contribution to the field of pharmaceutical compositions. He holds a total of eight patents, showcasing his dedication to innovation and research in the treatment of various disorders.
Latest Patents
Among his latest patents are compositions and formulations that utilize gamma-hydroxybutyrate (GHB) for the treatment of sleep disorders. These patents detail pharmaceutical compositions that include mixed salts of GHB and methods for their use in addressing conditions such as apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus. The innovative approaches outlined in these patents aim to improve the quality of life for individuals suffering from these disorders.
Career Highlights
Michael DesJardin has worked with prominent companies in the pharmaceutical industry, including Jazz Pharmaceuticals Ireland Limited and Jazz Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.
Collaborations
Throughout his career, DesJardin has collaborated with talented individuals such as Clark Patrick Allphin and Mark Johnson. These partnerships have fostered a creative environment that has led to significant innovations in the field.
Conclusion
Michael DesJardin's work in pharmaceutical compositions, particularly involving gamma-hydroxybutyrate, highlights his commitment to addressing critical health issues. His contributions continue to impact the treatment of sleep disorders, showcasing the importance of innovation in medicine.